Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Buy Rating for Geron with 4 Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Tech-banking-finance
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Needham analyst Gil Blum has once again expressed optimism for Geron (NASDAQ: GERN), reiterating a Buy rating and holding steady with a $4 price target. This reaffirmation of confidence in the stock‘s potential is in line with previous reports from Needham, highlighting a strong belief in Geron’s future success. The consensus among analysts remains overwhelmingly positive, with 4 stock analysts, including Needham, giving Geron a “Strong Buy” rating. This consistent show of support underscores a bright outlook for Geron’s performance and growth opportunities in the market.

Date: March 4, 2024

Geron Corporation (GERN) Stock Surges 13% on March 4, 2024: Positive Momentum Continues in Pre-Market Trading

On March 4, 2024, Geron Corporation (GERN) saw a significant increase in its stock performance. The price of GERN shares experienced a notable increase of $0.26 since the market last closed, representing a 13.00% rise from its previous closing price of $2.26. Additionally, in pre-market trading, the stock has continued to rise, with an additional $0.09 increase. This positive price momentum for GERN may be attributed to various factors such as positive news announcements, favorable market conditions, or increased investor confidence in the company’s prospects. Investors and analysts will likely be monitoring the stock closely to see if this upward trend continues throughout the trading day. Investors will be watching closely to see how the stock performs in the coming days and weeks.

Geron Corporation (GERN) Reports Decline in Revenue and Net Income for 2024, But Shows Improvement in Earnings Per Share

On March 4, 2024, Geron Corporation (GERN) saw a decline in its stock performance following the release of its financial results. The company reported a total revenue of $237.00K for the past year, marking a significant decrease of 60.23% compared to the previous year. Additionally, the total revenue for the last quarter was reported at $23.00K, showing a staggering decline of 85.98% since the previous quarter.

In terms of net income, Geron Corporation reported a net loss of -$184.13M for the past year, representing a decrease of 29.76% compared to the previous year. The net loss for the last quarter was reported at -$51.97M, marking a decrease of 16.0% since the previous quarter.

Despite the declines in total revenue and net income, Geron Corporation did see a slight improvement in its earnings per share (EPS) performance. The company reported an EPS of -$0.32 for the past year, which was an increase of 13.39% compared to the previous year. The EPS for the last quarter was reported at -$0.09, showing no change since the previous quarter.

Overall, the financial results released by Geron Corporation on March 4, 2024, reflected a challenging period for the company with declines in total revenue and net income. However, the slight improvement in EPS may provide some optimism for investors moving forward.

Tags: GERN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Bull Market

Analysts Bullish on Costco Wholesale Price Targets and Ratings

Biotechnology Stock Exchange

Durect Corporation and Charles River Laboratories Announce Partnership for Alzet Osmotic Pumps

FLO stock news

Baird Analyst Maintains Neutral Rating on MasTec with Raised Price Target

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com